---
title: Extended DOAC strategies-venous thromboembolism
---

# Extended DOAC strategies-venous thromboembolism

* After ≥6 mo of anticoag, following regimens compared w/ no extended Rx (or ASA):

## Full-dose DOAC:
	* 80–90% ↓ recurrent VTE, 2–5× bleeding,
	* but no signif excess in major bleeding
	* (NEJM 2010;363:2499; 2013;368:699 & 709)

## ½ dose apixa or riva:
	* ≥75% ↓ recur. VTE,
	* w/o ↑ bleeding (NEJM 2013;368:699 & 2017;376:1211)
